Escherichia coli cells carrying fosfomycin resistance plasmids were able to take up fosfomycin from the medium to the same extent as plasmid-free bacteria. The antibiotic entered the plasmid-harboring cells by means of the glpT and uhp transport systems, as is the case with susceptible bacteria. Active fosfomycin could be detected in soluble extracts of cells which had previously been incubated in the presence of the antibiotic. Furthermore, fosfomycin resistance plasmids did not confer on E. coli cells resistance to the novel antibiotic FR-31564, which is incorporated by the same transport systems as fosfomycin. We conclude that, in contrast to chromosomal resistance mutants, altered transport does not play a role in the plasmid-encoded fosfomycin resistance mechanism.
Fosfomycin (L-cis-1,2-epoxypropylphosphonic acid) is a broad-spectrum antibiotic used in some countries. It inactivates the enzyme phosphoenolpyruvate: UDP-N-acetylglucosamine enolpyruvyl transferase, which catalyzes one of the first steps in the process of cell wall biosynthesis (5) . Fosfomycin enters susceptible bacteria by means of at least two different transport systems. The first, the uhp system, mainly transports hexose phosphates. It needs to be induced by glucose 6-phosphate (G6P) and is present in several bacterial species, including Escherichia coli (13) . The second, the glpT transport system, transports L-a-glycerophosphate (aGP) and is partly constitutive. In many bacterial species it has been found to be the system used for the transport offosfomycin in the absence of G6P (5, 7).
Spontaneous mutants resistant to fosfomycin are easily obtained. They usually carry mutations on the chromosomal locus glpT and fail to grow on minimal ihedia containing aGP as the sole carbon source (5, 11) , but may become susceptible to fosfomycin if the uhp system is induced by the addition of CG6P (5). Fosfomycinresistant mutants having alterations in both the glpT and the uhp systems have also been obtained by growing E. coli GlpT-strains in the presence of fosfomycin and G6P (4).
We have described plasmids from clinical strains of Serratia marcescens conferring resistance to fosfomycin. These plasmids can be grouped into two types on the basis of their molecular masses and their resistance determinants. One type, represented by plasmid pOU900, codes for resistance to fosfomycin, carbenicillin, and streptomycin. It has a molecular mass of 57 megadaltons. The other type is represented by plasmid pOU500. It confers resistance to fosfomycin, carbenicillin, chloramphenicol, gentamicin, kanamycin, streptomycin, sulfonamide, tetracycline, and mercuric ions. Its molecular mass is 97 megadaltons (10) .
As a first step in determining the mechanism of plasmid-coded resistance, we have shown that the strains carrying plasmids, in contrast to those carrying chromosomal resistance genes, take up the antibiotic efficiently. This finding suggests that a different resistance mechanism operates in the plasmid-containing bacteria.
MATERIALS AND METHODS Antibiotics and chemicals. Fosfomycin and [1,2- 3Hlfosfomycin were a gift of Compafifa Espafiola de la Penicilina y Antibi6ticos. FR-31564 was kindly provided by Fujisawa Pharmaceutical Co. All of the chemicals used were reagent grade.
Media. The abilities of the different strains to use aGP or G6P as sole carbon source were tested by growing the bacteria in minimal salts medium supplemented with 40 mM aGP or 10 mM G6P. Minimal salts medium contained, per liter, Tris, 12 g; KCl, 2 g; NH4Cl, 2 g; MgCl2 * 6H20, 0.05 g; Na2HPO4, 0.178 g; Na2SO4, 0.05 g; and HCl up to pH 7. After autoclaving, ifitered solutions of aGP or G6P were added to give the above concentrations. L broth (LB) has been described elsewhere (7) . When necessary, the media were solidified with 1.2% (wt/vol) agar. Growth in liquid medium was monitored by following the absorbance at 590 nm in a Spectronic 20 colorimeter. Both minimal salts medium and LB were chosen for minimal medium growth tests and fosfomycin transport assays, respectively, because of their low phosphate ion content, reported to interfere with aGP (8) and G6P (2) transport.
Bacteria strains. E. coli 185 is an E. coli K-12 derivative resistant to nalidixic acid. Derivatives containing plasmids pOU500 and pOU900 were construct-608 on August 27, 2017 by guest http://aac.asm.org/ Downloaded from ed by conjugation, using S. marcescens strains SM5 and SM9, respectively, as donors (10) . E. coli 185(pOU500) and E. coli 185(pOU900) have been used in these studies as standard plasmid-mediated fosfomycin resistance strains. E. coli 185 fosfomycin-resistant mutants were selected by plating E. coli 185 on Lagar plates containing fosfomycin (100 ,ug/ml). The frequency of mutation was found to be 10-5 per cell.
Mutants were tested for growth on aGP and G6P minimal agar plates. All of them grew on plates containing G6P but not on aGP-containing plates. Some of these colonies were grown in LB containing 10 mM G6P and 20 ,ug of fosfomycin per ml for 6 h at 37°C. A 0.2-ml portion of this culture was spread on Lagar plates, and the colonies obtained were tested for their ability to grow in liquid medium containing G6P as sole carbon source. One of them, showing diminished growth on G6P minimal medium, was designated E. coli 185GP.
Determination of MICs. Minimal inhibitory concentrations (MICs) were determined by inoculating 10-2_ fold diluted overnight cultures on Mueller-Hinton agar plates containing different concentrations of fosfomycin or FR-31564, ranging from 42 mg/ml to 0.5 pg/ml.
Determination of active intracellular fosfomycin. The strain to be tested was grown in 20 ml of LB to an optical density of 0.2 at 590 nm. G6P was then added to give a concentration of 5 mM, and the culture was incubated for 90 min. The bacteria were then washed twice with fresh LB and finally resuspended in 1 ml of LB. This suspension was incubated for 40 min in the presence of 2 mg of fosfomycin per ml (14.7 mM). The bacteria were collected by centrifugation and washed with hypertonic buffer (10 mM Tris, 0.5 mM MgCl2, 150 mM NaCl, pH 7.3) to remove the antibiotic. Cells were resuspended in 2 ml of distilled water and ultrasonically disrupted (sonicator W-220F; Heat SystemsUltrasonic Inc.) with ten 30-s bursts followed by alternating 30-s cooling periods. Ultrasonic output was regulated at 50 W. The sonicated extract was centrifuged at 100,000 x g for 5 min, and the antibiotic concentration in the supernatant was determined by microbiological assay, using Staphylococcus aureus ATCC 25923 as the indicator strain. Control assays were carried out with extracts of each strain obtained by processing the cells immediately after fosfomycin addition (zero time). Proteins in the supernatants were determined by the method of Lowry et al. (9) , using serum albumin as the standard.
Fosfomycin uptake assays. The incorporation of fosfomycin was assayed with labeled [3H]fosfomycin. The transport experiments were carried out essentially as described by Kahan et al. (5) . Overnight cultures grown in LB were diluted 10-1-fold and incubated for 90 min at 37°C with shaking to reach an optical density of 0.3 at 590 nm. At this point aGP or G6P was added to give a final concentration of 5 mM, and the cultures were incubated for a further 90 min. Bacteria sedimented by centrifugation were washed with fresh LB without inducer and finally resuspended in one-fifth of their original volume of LB containing chloramphenicol (20 ,ug/ml). This cell suspension was mixed with 0.5 mM [3H]fosfomycin (specific activity, 14.4 mCi/ mmol). Periodically, 0.3-ml samples were removed and ifitered through membrane filters (0.22-,um pore size; Millipore Corp.). Filters were washed with 6 ml of the hypertonic buffer described above, and their coli 185 fosfomycin-resistant mutants were selected by a two-step procedure as described above. In the first step colonies growing on Lagar plates containing fosfomycin were tested for their ability to use aGP or G6P as sole energy source. Only mutants failing to grow on aGP were obtained. In a second step, these mutants were subjected to the action offosfomycin in the presence of G6P. Twenty survivors were retested for growth in liquid media containing G6P as sole carbon source. All grew at one-third of the growth rate of the parental E. coli 185. One of the mutants, E. coli 185GP, was chosen and used in subsequent experiments as a transportdefective fosfomycin-resistant mutant.
MICs. The MICs of fosfomycin were determined for all of the strains. Mutant E. coli 185GP was much less resistant (MIC, 750 FLg/ml) than the plasmid-carrying strains (MICs, 19,000 to 24,000 ,ug/ml), suggesting a difference in the resistance mechanism displayed by both types of resistant strains (Table 1) . MICs were also determined on Mueller-Hinton agar plates supplemented with 5 mM aGP or G6P. The presence of these compounds lowered the MIC of fosfomycin in all strains tested (Table 1) .
Permeability to fosfomycin of resistant strains.
To test whether the plasmid-carrying strains had functional glpT or uhp transport systems, we investigated the ability of E. coli 185(pOU500) and E. coli 185(pOU900) to grow in minimal salts medium supplemented with 40 mM aGP or 10 mM G6P. Both strains grew in these media at the same rate as the parental E. coli 185. Susceptibility to the novel antibiotic FR-31564 was also investigated. FR-31564 is a phosphonic acid derivative that enters the bacteria via the glpT transport system (6 antibiotic, presumably because of its failure to transport it.
To study the permeability of all three strains resistant to fosfomycin, we performed incorporation experiments, using [3H]fosfomycin. We first induced the transport systems by incubating the cells in the presence of aGP or G6P as described above. E. col 185 and its derivatives carrying plasmid pOU500 or pOU900 incorporated fosfomycin to the same extent, G6P being a more efficient inducer of fosfomycin transport than aGP (Fig. 1) . Fosfomycin incorporation was linear in these strains up to 60 min after addition of the antibiotic. The spontaneous mutant E. coili 185GP hardly incorporated any fosfomycin.
Direct evidence that fosfomycin was not only being incorporated but also using the gipT and uhp transport systems, as is the case with the susceptible strains, was obtained by competition experiments with labeled fosfomycin. Different concentrations of aGP and G6P, together with [3H]fosfomycin, were added to bacterial suspensions previously induced by those compounds. Inhibition of the incorporation of fosfomycin because of competition by aGP and G6P is shown in Fig. 2 . The competition profiles changed depending on which compound was used as inducer. In contrast, similar concentrations of other compounds not related to the substrates of the gipT and uhp systems, such as pyruvate, glycine, or lactose, did not affect fosfomycin incorporation.
Intracellular accumulation offosfomycin. Since radioactivity from labeled fosfomycin is incor- We have demonstrated that plasmid-bearing strains had efficient transport systems for aGP and G6P, as shown by their ability to use aGP and G6P as sole energy sources and by their susceptibility to FR-31564. Cross-resistance between fosfomycin and FR-31564 has been reported in mutants of several bacterial species (6) .
Biologically active fosfomycin was detected in extracts from cells incubated in the presence of the antibiotic. The amounts offosfomycin found were about the same in E. coli 185 extracts and in the extracts of its derivatives containing plasmids pOU500 and pOU900. However, it was much smaller in extracts of E. coli 185GP, and this observation is consistent with the failure of this strain to use aGP and G6P as energy sources. Analogous results were obtained when the incorporation of labeled fosfomycin into the bacteria was followed (Fig. 1) .
The competition effect mediated by aGP and G6P in [3Hlfosfomycin transport is shown in Fig. 2 . This result demonstrates that fosfomycin is being transported through the gipT and uhp transport systems in the plasmid-carrying strains, as is the case with susceptible bacteria. Moreover, the characteristics of the competition seen in Fig. 2 are consistent with the reported properties of the systems involved. The uhp system is absolutely dependent on induction by G6P. When G6P is used as inducer, the transport of labeled fosfomycin can be efficiently inhibited with G6P and a lesser inhibition is achieved with aGP because of the partial constitutivity of the glpT system (5, 8) . When aGP is used as inducer, fosfomycin transport is only inhibited by aGP, and this inhibition is stronger than in the previous cases because the uhp system shows no activity in the absence of induction by G6P (1, 3) . No major differences were observed between E. coli 185(pOU500) and E. coli 185(pOU900). The addition of aGP or G6P to the media resulted in a decrease in the MICs of plasmidcarrying strains. These data are similar to those obtained by others in fosfomycin-susceptible and chromosomal resistant strains (5, 12) . This result has been interpreted as indirect evidence for the transport of fosfomycin through the transport systems induced by those compounds; however, an antagonist effect would be expected from the transport competition data (Fig. 2) . The potentiating effect of aGP and G6P on the action of fosfomycin when they are present at concentrations much higher than their transport Km remains unexplained (1, 8) .
The results reported show that resistance to fosfomycin in the plasmid-bearing strains E. coli 185(pOU500) and E. coli 185(pOU900) cannot be due to a failure of the antibiotic to gain entry into the bacteria or to its destruction within the cells. On the other hand, destruction of fosfomycin in the growth media is not observed (data not shown). These observations, therefore, leave undetermined the resistance mechanism encoded by the plasmids under study. Currently, research is being carried out comparing the nature of the target enzyme offosfomycin action in susceptible and resistant strains.
